PMV Pharmaceuticals (PMVP) Short-term Investments (2019 - 2026)

PMV Pharmaceuticals (PMVP) has 7 years of Short-term Investments data on file, last reported at $54.4 million in Q1 2026.

• Quarterly Short-term Investments fell 50.1% year-over-year to $54.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.4 million (down 50.1% YoY) and the FY2025 annual result came in at $75.0 million, down 41.7% from the prior year.
• Short-term Investments slipped to $54.4 million in Q1 2026, from $75.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $149.9 million in Q3 2023 to a low of $822000.0 in Q1 2022.
• A 5-year average of $61.9 million and a median of $75.0 million in 2025 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments slumped 99.34% — and 2023, when it soared 18131.27%.
• Tracing PMVP's Short-term Investments over 5 years: stood at $822000.0 in 2022, then changed by 0.0% to $822000.0 in 2023, then jumped by 15542.09% to $128.6 million in 2024, then sank by 41.7% to $75.0 million in 2025, then dropped by 27.4% to $54.4 million in 2026.
• The last three Short-term Investments figures came in at $54.4 million (Q1 2026), $75.0 million (Q4 2025), and $92.9 million (Q3 2025), per Business Quant data.